Volitionrx (VNRX) Common Equity (2019 - 2025)
Historic Common Equity for Volitionrx (VNRX) over the last 9 years, with Q3 2025 value amounting to -$35.9 million.
- Volitionrx's Common Equity fell 5878.58% to -$35.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$35.9 million, marking a year-over-year decrease of 5878.58%. This contributed to the annual value of -$26.1 million for FY2024, which is 19966.79% down from last year.
- As of Q3 2025, Volitionrx's Common Equity stood at -$35.9 million, which was down 5878.58% from -$33.1 million recorded in Q2 2025.
- In the past 5 years, Volitionrx's Common Equity ranged from a high of $31.2 million in Q1 2021 and a low of -$35.9 million during Q3 2025
- Over the past 5 years, Volitionrx's median Common Equity value was -$3.0 million (recorded in 2023), while the average stood at -$4.4 million.
- Its Common Equity has fluctuated over the past 5 years, first skyrocketed by 23891.3% in 2021, then tumbled by 69403.14% in 2024.
- Quarter analysis of 5 years shows Volitionrx's Common Equity stood at $17.7 million in 2021, then tumbled by 117.64% to -$3.1 million in 2022, then plummeted by 178.62% to -$8.7 million in 2023, then tumbled by 199.67% to -$26.1 million in 2024, then tumbled by 37.7% to -$35.9 million in 2025.
- Its last three reported values are -$35.9 million in Q3 2025, -$33.1 million for Q2 2025, and -$29.0 million during Q1 2025.